Regulus Therapeutics Inc.
RGLS
$7.86
-$0.015-0.19%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.63M | -12.79M | -14.06M | -11.04M | -8.47M |
| Total Depreciation and Amortization | 85.00K | 87.00K | 90.00K | 89.00K | 81.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.05M | 2.08M | 1.83M | 1.17M | 1.15M |
| Change in Net Operating Assets | -3.11M | -1.22M | 2.69M | -1.86M | -1.50M |
| Cash from Operations | -10.61M | -11.85M | -9.45M | -11.64M | -8.74M |
| Capital Expenditure | -- | 0.00 | -28.00K | -83.00K | -229.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 21.50M | 24.00M | 18.67M | 0.00 | -78.32M |
| Cash from Investing | 21.50M | 24.00M | 18.64M | -83.00K | -78.54M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00 | 0.00 | -551.00K | -826.00K |
| Issuance of Common Stock | 45.00K | 64.00K | 6.00K | -- | 93.93M |
| Repurchase of Common Stock | -- | -- | -- | -74.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -64.00K | 50.00K | -119.00K | -- |
| Cash from Financing | 45.00K | 0.00 | 56.00K | -744.00K | 93.11M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.93M | 12.16M | 9.25M | -12.46M | 5.82M |